Depression worsens vascular, mortality outcomes in MS
Source: Adobe Stock September 13, 2021 Depression appeared to increase risk for incident vascular disease and mortality among individuals with…
Newer MS diagnostic criteria show ‘prognostic improvement’
September 27, 2021 Researchers observed a continuous decrease in the time to MS diagnosis and treatment initiation across diagnostic criteria…
Stuart Schlossman
Rituximab, ocrelizumab pose risks in patients with MS and COVID-19
October 07, 2021 Rituximab and ocrelizumab appeared to increase risk for adverse outcomes among patients with MS and COVID-19, according…
Stuart Schlossman
JC Virus Mutations May Predict Rare Brain Infection Linked to Tysabri
By Steve Bryson PhD on Oct 04, 2021 Mutations in the John Cunningham virus may serve as an early predictor…
Stuart Schlossman
Black People Undergoing MS Treatment Can Benefit From COVID Vaccines
New research may be a determining factor for Black multiple sclerosis (MS), who often experience different symptoms than those of…
Stuart Schlossman
Why Do Black Patients Fare Worse When MS Strikes?
While multiple sclerosis (MS) can cause a wide swath of symptoms and challenges for anyone diagnosed with the autoimmune disease, a…
Stuart Schlossman
Can MS Be Prevented?
Overview Multiple sclerosis (MS) is a disease of the central nervous system. More than 2.3 million people worldwide live with MS, estimates the…
Stuart Schlossman
Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab
September 23, 2021 Livnat Brill, PhD1; Ariel Rechtman, BSc1; Omri Zveik, BMedSc1; et al Nitzan Haham, BMedSc1; Esther Oiknine-Djian, PhD2,3; Dana G. Wolf, MD, PhD2,3; Netta Levin, MD, PhD1; Catarina Raposo, PhD4; Adi Vaknin-Dembinsky, MD, PhD1 Author Affiliations Article Information JAMA Neurol. Published online September 23, 2021. doi:10.1001/jamaneurol.2021.3599…
Stuart Schlossman
‘Shining a light on MS learnings from the COVID-19 pandemic’ – a PRISMS webinar
The first webinar will take place on September 23, 2021 at 2:30pm EDT until 3:30pmET Registrations are open at https://www.prismswebinar.online/user/register. The event…
Stuart Schlossman
Alarming COVID study indicates long-term loss of gray matter and other brain tissue
By Michael Greenwood, M.Sc. Jun 18 2021 There has been extensive evidence of brain-related pathologies associated with COVID-19…
Stuart Schlossman
